Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E (2023) Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 34(1):10–32. https://doi.org/10.1016/j.annonc.2022.10.003
Article CAS PubMed Google Scholar
Kitsel Y, Cooke T, Sotirchos V, Sofocleous CT (2023) Colorectal cancer liver metastases: genomics and biomarkers with focus on local therapies. Cancers 15(6):1679
Article CAS PubMed PubMed Central Google Scholar
Boeken T, Blons H, Dean C, Sapoval M, Pellerin O (2023) The potential of ctDNA in locoregional therapies for colorectal cancer. Lancet Gastroenterol Hepatol 8(12):1072–1073. https://doi.org/10.1016/S2468-1253(23)00323-0
Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B (2017) Local Treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djx015
Article PubMed PubMed Central Google Scholar
Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC (2014) Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg 259(6):1195–1200. https://doi.org/10.1097/sla.0000000000000234
de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250(3):440–448. https://doi.org/10.1097/SLA.0b013e3181b4539b
De Baere T, Tselikas L, Delpla A, Roux C, Varin E, Kobe A, Yevich S, Deschamps F (2022) Thermal ablation in the management of oligometastatic colorectal cancer. Int J Hyperthermia 39(1):627–632. https://doi.org/10.1080/02656736.2021.1941311
de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26(5):987–991. https://doi.org/10.1093/annonc/mdv037
Article PubMed PubMed Central Google Scholar
Puijk RS, Ruarus AH, Vroomen L, van Tilborg A, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR (2018) Colorectal liver metastases: surgery versus thermal ablation (COLLISION)—a phase III single-blind prospective randomized controlled trial. BMC Cancer 18(1):821. https://doi.org/10.1186/s12885-018-4716-8
Article PubMed PubMed Central Google Scholar
Minier C, Hermida M, Allimant C, Escal L, Pierredon-Foulongne MA, Belgour A, Piron L, Taourel P, Cassinotto C, Guiu B (2022) Software-based assessment of tumor margins after percutaneous thermal ablation of liver tumors: a systematic review. Diagn Interv Imaging 103(5):240–250. https://doi.org/10.1016/j.diii.2022.02.004
Pécuchet N, Rozenholc Y, Zonta E, Pietrasz D, Didelot A, Combe P, Gibault L, Bachet JB, Taly V, Fabre E, Blons H, Laurent-Puig P (2016) Analysis of base-position error rate of next-generation sequencing to detect tumor mutations in circulating DNA. Clin Chem 62(11):1492–1503. https://doi.org/10.1373/clinchem.2016.258236
Article CAS PubMed Google Scholar
Pécuchet N, Zonta E, Didelot A, Combe P, Thibault C, Gibault L, Lours C, Rozenholc Y, Taly V, Laurent-Puig P, Blons H, Fabre E (2016) Base-position error rate analysis of next-generation sequencing applied to circulating tumor DNA in non-small cell lung cancer: a prospective study. PLoS Med 13(12):e1002199. https://doi.org/10.1371/journal.pmed.1002199
Article CAS PubMed PubMed Central Google Scholar
Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P (2018) RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study. Ann Oncol 29(5):1211–1219. https://doi.org/10.1093/annonc/mdy061
Article CAS PubMed Google Scholar
Garrigou S, Perkins G, Garlan F, Normand C, Didelot A, Le Corre D, Peyvandi S, Mulot C, Niarra R, Aucouturier P, Chatellier G, Nizard P, Perez-Toralla K, Zonta E, Charpy C, Pujals A, Barau C, Bouché O, Emile JF, Pezet D, Bibeau F, Hutchison JB, Link DR, Zaanan A, Laurent-Puig P, Sobhani I, Taly V (2016) A Study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker. Clin Chem 62(8):1129–1139. https://doi.org/10.1373/clinchem.2015.253609
Article CAS PubMed Google Scholar
Calandri M, Siravegna G, Yevich SM, Stranieri G, Gazzera C, Kopetz S, Fonio P, Gupta S, Bardelli A, Veltri A, Odisio BC (2020) Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know. Eur Radiol 30(8):4496–4503. https://doi.org/10.1007/s00330-020-06700-4
Montagut C, Vidal J (2022) Liquid biopsy for precision adjuvant Chemotherapy in colon cancer. N Engl J Med 386(24):2330–2331. https://doi.org/10.1056/NEJMe2204625
Nassar A, Aly NE, Jin Z, Aly EH (2024) ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta-analysis. Colorectal Dis. https://doi.org/10.1111/codi.17039
Andersen L, Kisistok J, Henriksen TV, Bramsen JB, Reinert T, Ogaard N, Mattesen TB, Birkbak NJ, Andersen CL (2024) Exploring the biology of ctDNA release in colorectal cancer. Eur J Cancer 207:114186. https://doi.org/10.1016/j.ejca.2024.114186
Article CAS PubMed Google Scholar
Mandel P, Metais P (1948) Nuclear Acids In Human Blood Plasma. C R Seances Soc Biol Fil 142(3–4):241–243
Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37(3):646–650
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4):1659–1665
Kustanovich A, Schwartz R, Peretz T, Grinshpun A (2019) Life and death of circulating cell-free DNA. Cancer Biol Ther 20(8):1057–1067. https://doi.org/10.1080/15384047.2019.1598759
Article CAS PubMed PubMed Central Google Scholar
Wang W, Kong P, Ma G, Li L, Zhu J, Xia T, Xie H, Zhou W, Wang S (2017) Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget 8(26):43180
Article PubMed PubMed Central Google Scholar
Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I, Inoue T (2009) Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci 100(2):303–309. https://doi.org/10.1111/j.1349-7006.2008.01021.x
Article CAS PubMed Google Scholar
Boysen AK, Pallisgaard N, Andersen CSA, Spindler KG (2020) Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer. Acta Oncol 59(12):1424–1429. https://doi.org/10.1080/0284186x.2020.1806357
Article CAS PubMed Google Scholar
Tie J, Wang Y, Cohen J, Li L, Hong W, Christie M, Wong HL, Kosmider S, Wong R, Thomson B, Choi J, Fox A, Field K, Burge M, Shannon J, Kotasek D, Tebbutt NC, Karapetis C, Underhill C, Haydon A, Schaeffer J, Ptak J, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P (2021) Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study. PLoS Med 18(5):e1003620. https://doi.org/10.1371/journal.pmed.1003620
留言 (0)